Human Pathology
Volume 41, Issue 6 , Pages 815-823, June 2010

Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression☆☆★★

  • Béma Coulibaly, MD

      Affiliations

    • Département d'Anatomie Pathologie et de Neuropathologie, Centre Hospitalier Universitaire (CHU) Timone, 13005 Marseille, France
    • Laboratoire d'Angiogénèse, Invasion et Micro-environnement tumoral, Inserm Unité Mixte de Recherche (UMR) 911, Faculté de Médecine Timone, 13385 Marseille cedex 05, France
    • Corresponding Author InformationCorresponding author. Département de Neuropathologie, CHU Timone, 13005 Marseille, France.
  • ,
  • Isabelle Nanni, PharmD

      Affiliations

    • Laboratoire de transfert d'Oncologie Biologique, Faculté de Médecine Nord, 13016 Marseille, France
  • ,
  • Benoit Quilichini, MD

      Affiliations

    • Laboratoire d'Angiogénèse, Invasion et Micro-environnement tumoral, Inserm Unité Mixte de Recherche (UMR) 911, Faculté de Médecine Timone, 13385 Marseille cedex 05, France
  • ,
  • Jean Gaudart, MD, PhD

      Affiliations

    • Unité Fonctionnelle (UF) Biostatistique et Méthodologie de la Recherche Clinique, Service de Santé Publique et d'Information Médicale (SSPIM)/ Laboratoire d'Enseignement et de Recherche sur le Traitement de l'Information Médicale (LERTIM), CHU Timone, 13005 Marseille, France
  • ,
  • Philippe Metellus, MD

      Affiliations

    • Département de Neurochirurgie, CHU Timone, 13005 Marseille, France
  • ,
  • Frédéric Fina, PhD

      Affiliations

    • Laboratoire de transfert d'Oncologie Biologique, Faculté de Médecine Nord, 13016 Marseille, France
  • ,
  • Céline Boucard, MSc

      Affiliations

    • Département de Neuro-Oncologie, CHU Timone, 13005 Marseille, France
  • ,
  • Olivier Chinot, MD

      Affiliations

    • Département de Neuro-Oncologie, CHU Timone, 13005 Marseille, France
  • ,
  • L'Houcine Ouafik, PhD

      Affiliations

    • Laboratoire d'Angiogénèse, Invasion et Micro-environnement tumoral, Inserm Unité Mixte de Recherche (UMR) 911, Faculté de Médecine Timone, 13385 Marseille cedex 05, France
  • ,
  • Dominique Figarella-Branger, MD, PhD

      Affiliations

    • Département d'Anatomie Pathologie et de Neuropathologie, Centre Hospitalier Universitaire (CHU) Timone, 13005 Marseille, France
    • Laboratoire d'Angiogénèse, Invasion et Micro-environnement tumoral, Inserm Unité Mixte de Recherche (UMR) 911, Faculté de Médecine Timone, 13385 Marseille cedex 05, France

Received 28 April 2009; received in revised form 4 August 2009; accepted 10 September 2009. published online 19 March 2010.

Summary 

Epidermal growth factor receptor is a transmembrane receptor involved in oncogenesis, including the development of glioblastoma. We studied the prognostic significance of epidermal growth factor receptor amplification as determined by fluorescence in situ hybridization, quantitative polymerase chain reaction, and protein expression by immunohistochemistry. Ninety-nine patients exhibiting glioblastoma were included. Immunohistochemistry was performed on microarray blocks with clone 25, which recognizes both epidermal growth factor receptor wild type and vIII, and scored using a semiquantitative approach. Quantitative polymerase chain reaction and fluorescence in situ hybridization techniques were performed on frozen section: 29.3% of cases had a high epidermal growth factor receptor immunohistochemistry score (score ≥200); and of these cases, 96.5% had gene amplification by fluorescence in situ hybridization and quantitative polymerase chain reaction. Conversely, of cases with a low immunohistochemistry score, 72.9% had normal karyotype or polysomy 7 by fluorescence in situ hybridization technique; but around 25% had gene amplification by fluorescence in situ hybridization and quantitative polymerase chain reaction. In the case of protein overexpression, quantitative polymerase chain reaction and fluorescence in situ hybridization could be avoided in first intention because their positive predictive value for amplification is 97%. In multivariate analysis, there was a trend toward an association between shorter overall survival time and epidermal growth factor receptor amplification as determined by fluorescence in situ hybridization analysis. However, cases with an immunohistochemistry score less 200 require further testing by fluorescence in situ hybridization or quantitative polymerase chain reaction.

Keywords: Glioblastoma, Epidermal growth factor receptor, Immunohistochemistry, Gene amplification, Fluorescence in situ hybridization

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study has been reviewed by the relevant institutional review board (University of Aix-Marseille) and has been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. All patients gave their informed consent prior to their inclusion in the study.

☆☆ This work was supported by INCA (RS 019, gliother; Paris, France), by the PACA Canceropole (Marseille, France), by INSERM grants to CRO2 UMR 911 (Marseille, France), by Lionel Perrier Foundation (Montreux, Switzerland), and by the GEFLUC (Marseille, France).

 Disclosure of funding: none.

★★ The authors declare that they have no conflict of interest.

PII: S0046-8177(09)00462-6

doi:10.1016/j.humpath.2009.09.020

Human Pathology
Volume 41, Issue 6 , Pages 815-823, June 2010